Also, mRNA NRF2 levels were poor predictors to determine ferroptosis sensitivity in NSCLC, glioblastoma, osteosarcoma, and fibrosarcoma cells [24]. This evidence concerns the gene NFE2L2 and non-small cell lung carcinoma.